Double maintains 2 strategies that include LGND - Ligand Pharmaceuticals, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 58.57% | $4.85B | 0.35% |
IWO | 57.06% | $11.36B | 0.24% |
KJUL | 56.16% | $113.35M | 0.79% |
VTWO | 55.45% | $12.07B | 0.07% |
IWM | 55.33% | $63.95B | 0.19% |
SCHA | 55.15% | $16.91B | 0.04% |
KJAN | 54.94% | $305.13M | 0.79% |
IWC | 54.90% | $766.88M | 0.6% |
ISCG | 54.78% | $645.00M | 0.06% |
SMMD | 54.61% | $1.46B | 0.15% |
PTH | 54.59% | $96.56M | 0.6% |
NUSC | 54.50% | $1.14B | 0.31% |
ESML | 54.28% | $1.81B | 0.17% |
IBB | 54.23% | $5.22B | 0.45% |
GSSC | 54.03% | $538.65M | 0.2% |
VXF | 53.88% | $21.56B | 0.05% |
VB | 53.70% | $62.13B | 0.05% |
DFAS | 53.66% | $9.91B | 0.27% |
SMLF | 53.61% | $1.71B | 0.15% |
VBK | 53.54% | $18.33B | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -43.13% | $109.64M | 0.85% |
TAIL | -40.18% | $140.49M | 0.59% |
BTAL | -33.42% | $361.41M | 1.43% |
IVOL | -16.40% | $353.94M | 1.02% |
TBLL | -16.35% | $2.46B | 0.08% |
BIL | -13.10% | $45.95B | 0.1356% |
GBIL | -12.79% | $6.17B | 0.12% |
BILS | -12.69% | $3.96B | 0.1356% |
FTSD | -12.52% | $212.46M | 0.25% |
XONE | -12.49% | $603.24M | 0.03% |
FXY | -10.38% | $838.61M | 0.4% |
XHLF | -8.81% | $1.46B | 0.03% |
SPTS | -8.58% | $5.76B | 0.03% |
IBTG | -8.27% | $1.88B | 0.07% |
SHYM | -8.01% | $322.93M | 0.35% |
SCHO | -7.69% | $10.87B | 0.03% |
XBIL | -6.99% | $782.40M | 0.15% |
UTWO | -6.98% | $387.71M | 0.15% |
USDU | -6.79% | $173.44M | 0.5% |
BSMW | -6.76% | $102.62M | 0.18% |
Current Value
$103.001 Year Return
Current Value
$103.001 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ACLX | 52.04% | $3.22B | +10.72% | 0.00% |
ACIW | 50.41% | $5.12B | +32.02% | 0.00% |
ROIV | 49.53% | $7.68B | -5.70% | 0.00% |
BN | 49.48% | $98.39B | +33.78% | 0.55% |
BNT | 48.41% | $11.98B | +33.22% | 0.00% |
CLDT | 48.08% | $353.18M | -20.42% | 4.15% |
EMR | 47.82% | $67.64B | +6.59% | 1.76% |
DLX | 47.73% | $715.84M | -31.71% | 7.50% |
NNI | 47.51% | $4.35B | +9.24% | 0.94% |
SYRE | 47.22% | $877.54M | -61.53% | 0.00% |
DIOD | 47.10% | $2.25B | -33.06% | 0.00% |
MFC | 46.88% | $54.92B | +20.77% | 3.69% |
NDAQ | 46.80% | $46.66B | +30.61% | 1.18% |
FRSH | 46.61% | $4.57B | +11.85% | 0.00% |
ITT | 46.47% | $11.82B | +8.44% | 0.87% |
DNLI | 46.22% | $2.06B | -30.04% | 0.00% |
HBAN | 46.16% | $23.45B | +13.62% | 3.87% |
CRNX | 46.11% | $2.92B | -39.88% | 0.00% |
KYMR | 45.99% | $1.95B | -15.67% | 0.00% |
KN | 45.75% | $1.48B | -2.96% | 0.00% |
Yahoo
JUPITER, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that the company will ring The Nasdaq Stock Market Opening Bell on Monday, May 19, 2025. CEO Todd Davis will be joined by members of Ligand’s senior management team and board of directors to commemorate several recent company milestones, including two value-creating transactions. “Ringing the Nasdaq Opening Bell marks an exciting milestone in our company’s history. Over the past few
Yahoo
By John Vandermosten, CFA NASDAQ:LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) reported first quarter 2025 financial and operational results posting revenues of $45.3 million, a 46% rise over prior year levels. Drivers for the result were a seven-fold increase in financial royalty revenue, a 46% increase in Captisol revenue and a 64% increase in Contract
Yahoo
Ligand Pharmaceuticals ( NASDAQ:LGND ) First Quarter 2025 Results Key Financial Results Revenue: US$45.3m (up 46% from...
Yahoo
Despite a challenging biopharmaceutical environment, Ligand Pharmaceuticals Inc (LGND) reports significant revenue growth and strategic advancements.
SeekingAlpha
The following slide deck was published by Ligand Pharmaceuticals Incorporated in conjunction with their 2025 Q1 earnings call.
SeekingAlpha
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ETCompany ParticipantsMelanie Herman â Executive...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HSY | -12.52% | $33.16B | -21.37% | 3.44% |
CBOE | -12.38% | $22.95B | +20.67% | 1.12% |
FMTO | -7.83% | $45.74M | -99.96% | 0.00% |
VSA | -7.57% | $7.04M | -49.24% | 0.00% |
DUK | -6.54% | $90.12B | +12.74% | 3.61% |
UTZ | -5.93% | $1.11B | -29.27% | 1.86% |
HIHO | -5.40% | $8.25M | -10.29% | 3.73% |
BCE | -4.99% | $19.94B | -37.01% | 13.15% |
ASPS | -4.69% | $69.98M | -57.72% | 0.00% |
K | -4.52% | $28.49B | +32.17% | 2.77% |
STG | -4.13% | $27.05M | -37.35% | 0.00% |
MO | -4.04% | $97.80B | +26.35% | 6.94% |
SO | -3.81% | $96.04B | +10.08% | 3.29% |
UUU | -3.79% | $4.93M | +40.20% | 0.00% |
CME | -3.52% | $98.74B | +28.80% | 3.84% |
AMT | -3.48% | $99.10B | +8.59% | 3.09% |
ED | -3.07% | $36.75B | +5.26% | 3.28% |
LITB | -2.80% | $21.28M | -72.45% | 0.00% |
KO | -2.55% | $308.23B | +13.09% | 2.75% |
IMMP | -2.55% | $289.16M | -32.19% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BGS | -0.02% | $355.90M | -53.30% | 17.00% |
AQB | 0.28% | $2.96M | -61.58% | 0.00% |
FUBO | -0.28% | $1.01B | +121.80% | 0.00% |
KDP | -0.30% | $45.55B | -1.76% | 2.70% |
CVM | -0.33% | $19.46M | -83.48% | 0.00% |
SRRK | 0.48% | $2.92B | +115.29% | 0.00% |
WTRG | 0.61% | $10.70B | -3.17% | 3.41% |
XRAY | -0.63% | $3.29B | -41.86% | 3.88% |
GFI | 0.74% | $18.61B | +31.67% | 2.75% |
TU | 0.77% | $23.77B | -4.62% | 7.19% |
CCEC | 0.79% | $1.02B | +3.91% | 2.71% |
PRPO | 0.86% | $10.84M | +15.14% | 0.00% |
MDLZ | 0.88% | $84.34B | -9.43% | 2.85% |
MSIF | 0.93% | $715.25M | +28.42% | 7.05% |
CPSH | 1.01% | $27.45M | +8.62% | 0.00% |
CIG.C | 1.01% | $2.45B | +9.77% | 0.00% |
IMAB | 1.04% | $69.58M | -50.00% | 0.00% |
VSTA | 1.12% | $326.82M | +11.64% | 0.00% |
CL | 1.36% | $72.64B | -5.18% | 2.25% |
NOC | 1.41% | $67.51B | -0.35% | 1.76% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IEI | -0.05% | $16.09B | 0.15% |
CARY | -0.31% | $347.36M | 0.8% |
IBMO | 0.32% | $512.46M | 0.18% |
MLN | 0.38% | $532.71M | 0.24% |
IBTJ | -0.39% | $658.04M | 0.07% |
GSST | 0.48% | $857.21M | 0.16% |
GSY | 0.49% | $2.79B | 0.22% |
MMIT | 0.52% | $829.60M | 0.3% |
BUXX | 0.63% | $284.43M | 0.25% |
IBMN | 0.64% | $446.12M | 0.18% |
SMMU | -0.74% | $822.53M | 0.35% |
TAXF | -0.74% | $500.81M | 0.29% |
BSSX | 0.84% | $75.11M | 0.18% |
SGOV | -0.84% | $45.91B | 0.09% |
VGIT | 0.85% | $31.33B | 0.04% |
VTIP | -0.87% | $14.78B | 0.03% |
IBTF | 0.97% | $2.12B | 0.07% |
TFI | 1.13% | $3.15B | 0.23% |
BSMR | 1.25% | $245.57M | 0.18% |
LDUR | -1.30% | $849.09M | 0.5% |